APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Selected research

Industry Growth & Trends

Global Mesalazine Industry Growth and Trends Forecast to 2032

30 December 2025111 pages

Choose your research edition.

Industry ResearchMesalazine Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Mesalazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The industry's leading manufacturers are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. In terms of regions, the revenue share in Europe is the highest, reaching 43% in 2021, followed by Asia Pacific with a share about 31%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Mesalazine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mesalazine market size, estimates, and forecasts are presented in terms of sales volume (Ton) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mesalazine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mesalazine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mesalazine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mesalazine Market by Company

PharmaZell

Syntese A/S

Cambrex Corporation

Divis Laboratories

Chemi SpA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalazine Segment by Purity

Above 97 %

Above 98 %

Above 99 %

Mesalazine Segment by Application

Tablets

Capsules

Pellet and Granule

Suppository

Enema

Others

Mesalazine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mesalazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Above 97 % Table 2. Major Company of Above 98 % Table 3. Major Company of Above 99 % Table 4. Global Mesalazine Sales by Purity (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Mesalazine Sales by Purity (2021-2026) & (Ton) Table 6. Global Mesalazine Sales Market Share in Volume by Purity (2021-2026) Table 7. Global Mesalazine Sales by Purity (2021-2026) & (US$ Million) Table 8. Global Mesalazine Sales Market Share in Value by Purity (2021-2026) Table 9. Global Mesalazine Price by Purity (2021-2026) & (US$/Kg) Table 10. Global Mesalazine Sales by Purity (2027-2032) & (Ton) Table 11. Global Mesalazine Sales Market Share in Volume by Purity (2027-2032) Table 12. Global Mesalazine Sales by Purity (2027-2032) & (US$ Million) Table 13. Global Mesalazine Sales Market Share in Value by Purity (2027-2032) Table 14. Global Mesalazine Price by Purity (2027-2032) & (US$/Kg) Table 15. North America Mesalazine Sales by Purity (2021-2026) & (Ton) Table 16. North America Mesalazine Sales by Purity (2021-2026) & (US$ Million) Table 17. Europe Mesalazine Sales by Purity (2021-2026) & (Ton) Table 18. Europe Mesalazine Sales by Purity (2021-2026) & (US$ Million) Table 19. Asia-Pacific Mesalazine Sales by Purity (2021-2026) & (Ton) Table 20. Asia-Pacific Mesalazine Sales by Purity (2021-2026) & (US$ Million) Table 21. Latin America Mesalazine Sales by Purity (2021-2026) & (Ton) Table 22. Latin America Mesalazine Sales by Purity (2021-2026) & (US$ Million) Table 23. Middle East and Africa Mesalazine Sales by Purity (2021-2026) & (Ton) Table 24. Middle East and Africa Mesalazine Sales by Purity (2021-2026) & (US$ Million) Table 25. Mesalazine Industry Trends Table 26. Mesalazine Industry Drivers Table 27. Mesalazine Industry Opportunities and Challenges Table 28. Mesalazine Industry Restraints Table 29. Global Mesalazine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Mesalazine Revenue Market Share by Company (2021-2026) Table 31. Global Mesalazine Sales by Company (2021-2026) & (Ton) Table 32. Global Mesalazine Sales Share by Company (2021-2026) Table 33. Global Mesalazine Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Mesalazine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Mesalazine Major Company Production Sites and Headquarters Table 36. Global Mesalazine Company, Product Type & Application Table 37. Global Mesalazine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Mesalazine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Mesalazine Sales by Region (2021-2026) & (Ton) Table 42. Global Mesalazine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Mesalazine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Mesalazine Sales Market Share in Value by Region (2021-2026) Table 45. Global Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Mesalazine Sales by Region (2027-2032) & (Ton) Table 47. Global Mesalazine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Mesalazine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Mesalazine Sales Market Share in Value by Region (2027-2032) Table 50. Global Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Mesalazine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Mesalazine Sales by Application (2021-2026) & (Ton) Table 53. Global Mesalazine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Mesalazine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Mesalazine Sales Market Share in Value by Application (2021-2026) Table 56. Global Mesalazine Price by Application (2021-2026) & (US$/Kg) Table 57. Global Mesalazine Sales by Application (2027-2032) & (Ton) Table 58. Global Mesalazine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Mesalazine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Mesalazine Sales Market Share in Value by Application (2027-2032) Table 61. Global Mesalazine Price by Application (2027-2032) & (US$/Kg) Table 62. North America Mesalazine Sales by Application (2021-2026) & (Ton) Table 63. North America Mesalazine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Mesalazine Sales by Application (2021-2026) & (Ton) Table 65. Europe Mesalazine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Mesalazine Sales by Application (2021-2026) & (Ton) Table 67. Asia-Pacific Mesalazine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Mesalazine Sales by Application (2021-2026) & (Ton) Table 69. Latin America Mesalazine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Mesalazine Sales by Application (2021-2026) & (Ton) Table 71. Middle East and Africa Mesalazine Sales by Application (2021-2026) & (US$ Million) Table 72. PharmaZell Company Information Table 73. PharmaZell Business Overview Table 74. PharmaZell Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. PharmaZell Mesalazine Product Portfolio Table 76. PharmaZell Recent Development Table 77. Syntese A/S Company Information Table 78. Syntese A/S Business Overview Table 79. Syntese A/S Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Syntese A/S Mesalazine Product Portfolio Table 81. Syntese A/S Recent Development Table 82. Cambrex Corporation Company Information Table 83. Cambrex Corporation Business Overview Table 84. Cambrex Corporation Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Cambrex Corporation Mesalazine Product Portfolio Table 86. Cambrex Corporation Recent Development Table 87. Divis Laboratories Company Information Table 88. Divis Laboratories Business Overview Table 89. Divis Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Divis Laboratories Mesalazine Product Portfolio Table 91. Divis Laboratories Recent Development Table 92. Chemi SpA Company Information Table 93. Chemi SpA Business Overview Table 94. Chemi SpA Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Chemi SpA Mesalazine Product Portfolio Table 96. Chemi SpA Recent Development Table 97. Ipca Laboratories Company Information Table 98. Ipca Laboratories Business Overview Table 99. Ipca Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Ipca Laboratories Mesalazine Product Portfolio Table 101. Ipca Laboratories Recent Development Table 102. Hangzhou Brother Company Information Table 103. Hangzhou Brother Business Overview Table 104. Hangzhou Brother Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Hangzhou Brother Mesalazine Product Portfolio Table 106. Hangzhou Brother Recent Development Table 107. Lianyungang Fengheng Biopharm Company Information Table 108. Lianyungang Fengheng Biopharm Business Overview Table 109. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Lianyungang Fengheng Biopharm Mesalazine Product Portfolio Table 111. Lianyungang Fengheng Biopharm Recent Development Table 112. Lasa Loboratory Company Information Table 113. Lasa Loboratory Business Overview Table 114. Lasa Loboratory Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Lasa Loboratory Mesalazine Product Portfolio Table 116. Lasa Loboratory Recent Development Table 117. Corden Pharma Bergamo Company Information Table 118. Corden Pharma Bergamo Business Overview Table 119. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Corden Pharma Bergamo Mesalazine Product Portfolio Table 121. Corden Pharma Bergamo Recent Development Table 122. Erregierre SpA Company Information Table 123. Erregierre SpA Business Overview Table 124. Erregierre SpA Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 125. Erregierre SpA Mesalazine Product Portfolio Table 126. Erregierre SpA Recent Development Table 127. CTX Lifescience Company Information Table 128. CTX Lifescience Business Overview Table 129. CTX Lifescience Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 130. CTX Lifescience Mesalazine Product Portfolio Table 131. CTX Lifescience Recent Development Table 132. Ishita Active Pharma Ingredients Company Information Table 133. Ishita Active Pharma Ingredients Business Overview Table 134. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 135. Ishita Active Pharma Ingredients Mesalazine Product Portfolio Table 136. Ishita Active Pharma Ingredients Recent Development Table 137. YC Biotech (Jiangsu) Company Information Table 138. YC Biotech (Jiangsu) Business Overview Table 139. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 140. YC Biotech (Jiangsu) Mesalazine Product Portfolio Table 141. YC Biotech (Jiangsu) Recent Development Table 142. Xinxiang Tianfeng Fine Chemical Company Information Table 143. Xinxiang Tianfeng Fine Chemical Business Overview Table 144. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 145. Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio Table 146. Xinxiang Tianfeng Fine Chemical Recent Development Table 147. North America Mesalazine Market Size Growth Rate (CAGR) by Country (Ton): 2021 VS 2025 VS 2032 Table 148. North America Mesalazine Sales by Country (2021-2026) & (Ton) Table 149. North America Mesalazine Sales Market Share by Country (2021-2026) Table 150. North America Mesalazine Sales Forecast by Country (2027-2032) & (Ton) Table 151. North America Mesalazine Sales Market Share Forecast by Country (2027-2032) Table 152. North America Mesalazine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Mesalazine Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Mesalazine Market Share by Country (2021-2026) Table 155. North America Mesalazine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Mesalazine Market Share Forecast by Country (2027-2032) Table 157. Europe Mesalazine Market Size Growth Rate (CAGR) by Country (Ton): 2021 VS 2025 VS 2032 Table 158. Europe Mesalazine Sales by Country (2021-2026) & (Ton) Table 159. Europe Mesalazine Sales Market Share by Country (2021-2026) Table 160. Europe Mesalazine Sales Forecast by Country (2027-2032) & (Ton) Table 161. Europe Mesalazine Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Mesalazine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Mesalazine Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Mesalazine Market Share by Country (2021-2026) Table 165. Europe Mesalazine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Mesalazine Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Mesalazine Market Size Growth Rate (CAGR) by Country (Ton): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Mesalazine Sales by Country (2021-2026) & (Ton) Table 169. Asia-Pacific Mesalazine Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Mesalazine Sales Forecast by Country (2027-2032) & (Ton) Table 171. Asia-Pacific Mesalazine Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Mesalazine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Mesalazine Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Mesalazine Market Share by Country (2021-2026) Table 175. Asia-Pacific Mesalazine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Mesalazine Market Share Forecast by Country (2027-2032) Table 177. Latin America Mesalazine Market Size Growth Rate (CAGR) by Country (Ton): 2021 VS 2025 VS 2032 Table 178. Latin America Mesalazine Sales by Country (2021-2026) & (Ton) Table 179. Latin America Mesalazine Sales Market Share by Country (2021-2026) Table 180. Latin America Mesalazine Sales Forecast by Country (2027-2032) & (Ton) Table 181. Latin America Mesalazine Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Mesalazine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Mesalazine Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Mesalazine Market Share by Country (2021-2026) Table 185. Latin America Mesalazine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Mesalazine Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Mesalazine Market Size Growth Rate (CAGR) by Country (Ton): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Mesalazine Sales by Country (2021-2026) & (Ton) Table 189. Middle East and Africa Mesalazine Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Mesalazine Sales Forecast by Country (2027-2032) & (Ton) Table 191. Middle East and Africa Mesalazine Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Mesalazine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Mesalazine Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Mesalazine Market Share by Country (2021-2026) Table 195. Middle East and Africa Mesalazine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Mesalazine Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Mesalazine Distributors List Table 200. Mesalazine Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Mesalazine Image Figure 2. Global Mesalazine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesalazine Sales (2021-2032) & (Ton) Figure 5. Above 97 % Image Figure 6. Global Above 97 % Sales YoY Growth (2021-2032) & (Ton) Figure 7. Above 98 % Image Figure 8. Global Above 98 % Sales YoY Growth (2021-2032) & (Ton) Figure 9. Above 99 % Image Figure 10. Global Above 99 % Sales YoY Growth (2021-2032) & (Ton) Figure 11. Global Mesalazine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Mesalazine Market Share by Type 2025 VS 2032 Figure 13. North America Mesalazine Sales Market Share in Volume by Type in 2025 Figure 14. North America Mesalazine Sales Market Share in Value by Type in 2025 Figure 15. Europe Mesalazine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Mesalazine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Mesalazine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Mesalazine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Mesalazine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Mesalazine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Mesalazine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Mesalazine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Mesalazine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Tablets Image Figure 26. Global Tablets Sales YoY Growth (2021-2032) & (Ton) Figure 27. Capsules Image Figure 28. Global Capsules Sales YoY Growth (2021-2032) & (Ton) Figure 29. Pellet and Granule Image Figure 30. Global Pellet and Granule Sales YoY Growth (2021-2032) & (Ton) Figure 31. Suppository Image Figure 32. Global Suppository Sales YoY Growth (2021-2032) & (Ton) Figure 33. Enema Image Figure 34. Global Enema Sales YoY Growth (2021-2032) & (Ton) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (Ton) Figure 37. Global Mesalazine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Mesalazine Market Share by Application 2025 VS 2032 Figure 39. North America Mesalazine Sales Market Share in Volume by Application in 2025 Figure 40. North America Mesalazine Sales Market Share in Value by Application in 2025 Figure 41. Europe Mesalazine Sales Market Share in Volume by Application in 2025 Figure 42. Europe Mesalazine Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Mesalazine Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Mesalazine Sales Market Share in Value by Application in 2025 Figure 45. Latin America Mesalazine Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Mesalazine Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Mesalazine Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Mesalazine Sales Market Share in Value by Application in 2025 Figure 49. North America Mesalazine Sales by Country: 2021 VS 2025 VS 2032 (Ton) Figure 50. North America Mesalazine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Mesalazine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Mesalazine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Mesalazine Sales by Country: 2021 VS 2025 VS 2032 (Ton) Figure 54. Europe Mesalazine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Mesalazine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Mesalazine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Mesalazine Sales by Country: 2021 VS 2025 VS 2032 (Ton) Figure 58. Asia-Pacific Mesalazine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Mesalazine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Mesalazine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Mesalazine Sales by Country: 2021 VS 2025 VS 2032 (Ton) Figure 62. Latin America Mesalazine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Mesalazine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Mesalazine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Mesalazine Sales by Country: 2021 VS 2025 VS 2032 (Ton) Figure 66. Middle East and Africa Mesalazine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Mesalazine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Mesalazine Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Mesalazine Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Mesalazine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Above 97 %
  • Above 98 %
  • Above 99 %
Applications
  • Tablets
  • Capsules
  • Pellet and Granule
  • Suppository
  • Enema
  • Others
Companies covered
  • PharmaZell
  • Syntese A/S
  • Cambrex Corporation
  • Divis Laboratories
  • Chemi SpA
  • Ipca Laboratories
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Corden Pharma Bergamo
  • Erregierre SpA
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalazine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesalazine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mesalazine Market by Purity
  6. 1.3.1 Above 97 %
  7. 1.3.2 Above 98 %
  8. 1.3.3 Above 99 %
  9. 1.4 Global Mesalazine Market Size by Purity
  10. 1.4.1 Global Mesalazine Market Size Overview by Purity (2021-2032)
  11. 1.4.2 Global Mesalazine Historic Market Size Review by Purity (2021-2026)
  12. 1.4.3 Global Mesalazine Forecasted Market Size by Purity (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Mesalazine Sales Breakdown by Purity (2021-2026)
  15. 1.5.2 Europe Mesalazine Sales Breakdown by Purity (2021-2026)
  16. 1.5.3 Asia-Pacific Mesalazine Sales Breakdown by Purity (2021-2026)
  17. 1.5.4 South America Mesalazine Sales Breakdown by Purity (2021-2026)
  18. 1.5.5 Middle East and Africa Mesalazine Sales Breakdown by Purity (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mesalazine Industry Trends
  2. 2.2 Mesalazine Industry Drivers
  3. 2.3 Mesalazine Industry Opportunities and Challenges
  4. 2.4 Mesalazine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mesalazine Revenue (2021-2026)
  2. 3.2 Global Top Players by Mesalazine Sales (2021-2026)
  3. 3.3 Global Top Players by Mesalazine Price (2021-2026)
  4. 3.4 Global Mesalazine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalazine Major Company Production Sites & Headquarters
  6. 3.6 Global Mesalazine Company, Product Type & Application
  7. 3.7 Global Mesalazine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalazine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalazine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesalazine Tier 1, Tier 2, and Tier 3
4 Mesalazine Regional Status and Outlook
  1. 4.1 Global Mesalazine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mesalazine Historic Market Size by Region
  3. 4.2.1 Global Mesalazine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mesalazine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mesalazine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mesalazine Forecasted Market Size by Region
  7. 4.3.1 Global Mesalazine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mesalazine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mesalazine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mesalazine by Application
  1. 5.1 Mesalazine Market by Application
  2. 5.1.1 Tablets
  3. 5.1.2 Capsules
  4. 5.1.3 Pellet and Granule
  5. 5.1.4 Suppository
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalazine Market Size by Application
  9. 5.2.1 Global Mesalazine Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Mesalazine Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Mesalazine Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Mesalazine Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Mesalazine Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Mesalazine Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Mesalazine Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Mesalazine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 PharmaZell
  2. 6.1.1 PharmaZell Company Information
  3. 6.1.2 PharmaZell Business Overview
  4. 6.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 PharmaZell Mesalazine Product Portfolio
  6. 6.1.5 PharmaZell Recent Developments
  7. 6.2 Syntese A/S
  8. 6.2.1 Syntese A/S Company Information
  9. 6.2.2 Syntese A/S Business Overview
  10. 6.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Syntese A/S Mesalazine Product Portfolio
  12. 6.2.5 Syntese A/S Recent Developments
  13. 6.3 Cambrex Corporation
  14. 6.3.1 Cambrex Corporation Company Information
  15. 6.3.2 Cambrex Corporation Business Overview
  16. 6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cambrex Corporation Mesalazine Product Portfolio
  18. 6.3.5 Cambrex Corporation Recent Developments
  19. 6.4 Divis Laboratories
  20. 6.4.1 Divis Laboratories Company Information
  21. 6.4.2 Divis Laboratories Business Overview
  22. 6.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Divis Laboratories Mesalazine Product Portfolio
  24. 6.4.5 Divis Laboratories Recent Developments
  25. 6.5 Chemi SpA
  26. 6.5.1 Chemi SpA Company Information
  27. 6.5.2 Chemi SpA Business Overview
  28. 6.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chemi SpA Mesalazine Product Portfolio
  30. 6.5.5 Chemi SpA Recent Developments
  31. 6.6 Ipca Laboratories
  32. 6.6.1 Ipca Laboratories Company Information
  33. 6.6.2 Ipca Laboratories Business Overview
  34. 6.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ipca Laboratories Mesalazine Product Portfolio
  36. 6.6.5 Ipca Laboratories Recent Developments
  37. 6.7 Hangzhou Brother
  38. 6.7.1 Hangzhou Brother Company Information
  39. 6.7.2 Hangzhou Brother Business Overview
  40. 6.7.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hangzhou Brother Mesalazine Product Portfolio
  42. 6.7.5 Hangzhou Brother Recent Developments
  43. 6.8 Lianyungang Fengheng Biopharm
  44. 6.8.1 Lianyungang Fengheng Biopharm Company Information
  45. 6.8.2 Lianyungang Fengheng Biopharm Business Overview
  46. 6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
  48. 6.8.5 Lianyungang Fengheng Biopharm Recent Developments
  49. 6.9 Lasa Loboratory
  50. 6.9.1 Lasa Loboratory Company Information
  51. 6.9.2 Lasa Loboratory Business Overview
  52. 6.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lasa Loboratory Mesalazine Product Portfolio
  54. 6.9.5 Lasa Loboratory Recent Developments
  55. 6.10 Corden Pharma Bergamo
  56. 6.10.1 Corden Pharma Bergamo Company Information
  57. 6.10.2 Corden Pharma Bergamo Business Overview
  58. 6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
  60. 6.10.5 Corden Pharma Bergamo Recent Developments
  61. 6.11 Erregierre SpA
  62. 6.11.1 Erregierre SpA Company Information
  63. 6.11.2 Erregierre SpA Business Overview
  64. 6.11.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Erregierre SpA Mesalazine Product Portfolio
  66. 6.11.5 Erregierre SpA Recent Developments
  67. 6.12 CTX Lifescience
  68. 6.12.1 CTX Lifescience Company Information
  69. 6.12.2 CTX Lifescience Business Overview
  70. 6.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CTX Lifescience Mesalazine Product Portfolio
  72. 6.12.5 CTX Lifescience Recent Developments
  73. 6.13 Ishita Active Pharma Ingredients
  74. 6.13.1 Ishita Active Pharma Ingredients Company Information
  75. 6.13.2 Ishita Active Pharma Ingredients Business Overview
  76. 6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
  78. 6.13.5 Ishita Active Pharma Ingredients Recent Developments
  79. 6.14 YC Biotech (Jiangsu)
  80. 6.14.1 YC Biotech (Jiangsu) Company Information
  81. 6.14.2 YC Biotech (Jiangsu) Business Overview
  82. 6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
  84. 6.14.5 YC Biotech (Jiangsu) Recent Developments
  85. 6.15 Xinxiang Tianfeng Fine Chemical
  86. 6.15.1 Xinxiang Tianfeng Fine Chemical Company Information
  87. 6.15.2 Xinxiang Tianfeng Fine Chemical Business Overview
  88. 6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
  90. 6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments
7 North America by Country
  1. 7.1 North America Mesalazine Sales by Country
  2. 7.1.1 North America Mesalazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mesalazine Sales by Country (2021-2026)
  4. 7.1.3 North America Mesalazine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mesalazine Market Size by Country
  6. 7.2.1 North America Mesalazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mesalazine Market Size by Country (2021-2026)
  8. 7.2.3 North America Mesalazine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mesalazine Sales by Country
  2. 8.1.1 Europe Mesalazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mesalazine Sales by Country (2021-2026)
  4. 8.1.3 Europe Mesalazine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mesalazine Market Size by Country
  6. 8.2.1 Europe Mesalazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mesalazine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mesalazine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mesalazine Sales by Country
  2. 9.1.1 Asia-Pacific Mesalazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mesalazine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mesalazine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mesalazine Market Size by Country
  6. 9.2.1 Asia-Pacific Mesalazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mesalazine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mesalazine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mesalazine Sales by Country
  2. 10.1.1 South America Mesalazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mesalazine Sales by Country (2021-2026)
  4. 10.1.3 South America Mesalazine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mesalazine Market Size by Country
  6. 10.2.1 South America Mesalazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mesalazine Market Size by Country (2021-2026)
  8. 10.2.3 South America Mesalazine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mesalazine Sales by Country
  2. 11.1.1 Middle East and Africa Mesalazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mesalazine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mesalazine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mesalazine Market Size by Country
  6. 11.2.1 Middle East and Africa Mesalazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mesalazine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mesalazine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mesalazine Value Chain Analysis
  2. 12.1.1 Mesalazine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mesalazine Production Mode & Process
  7. 12.2 Mesalazine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mesalazine Distributors
  10. 12.2.3 Mesalazine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst